CVS Health (CVS) Misses Q1 EPS by 38c; Lowers Outlook
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $101.57 +0.27%
Revenue Growth %: +1.2%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +1.2%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $1.33, $0.38 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $88.4 billion versus the consensus estimate of $89.33 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of $7.00, versus the consensus of $8.28.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- CVS Pharmacy® expands GLP‑1 support to lower costs, improve access, and help patients stay on therapy
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
